simendan has been researched along with Heart Failure, Systolic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ammendola, E; D'Alterio, G; Gravino, R; Masarone, D; Pacileo, G; Petraio, A; Valente, F; Verrengia, M | 1 |
| Karayiannis, G; Kirlidis, TT; Skoularigis, J; Triposkiadis, F; Tsaknakis, KT; Tsaknakis, TK | 1 |
| Karahan, O; Katrancioglu, N; Tandogan, I; Yilmaz, MB; Yontar, OC; Yücel, H; Zorlu, A | 1 |
1 trial(s) available for simendan and Heart Failure, Systolic
| Article | Year |
|---|---|
The influence of beta-blockade on the hemodynamic effects of levosimendan in elderly (>or= 70 years) patients with acutely decompensated systolic heart failure.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Heart Failure, Systolic; Hemodynamics; Humans; Hydrazones; Pyridazines; Simendan | 2009 |
2 other study(ies) available for simendan and Heart Failure, Systolic
| Article | Year |
|---|---|
Efficacy and safety of repeated infusion of levosimendan in outpatients with advanced heart failure: a real-world experience.
Topics: Adult; Aged; Ambulatory Care; Cardiovascular Agents; Exercise Tolerance; Female; Functional Status; Heart Failure, Systolic; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Recovery of Function; Simendan; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2020 |
Effect of levosimendan in patients with severe systolic heart failure and worsening renal function.
Topics: Aged; Cardiotonic Agents; Creatinine; Female; Glomerular Filtration Rate; Heart Failure, Systolic; Humans; Hydrazones; Kidney; Male; Middle Aged; Pyridazines; Renal Insufficiency; Retrospective Studies; Simendan; Statistics, Nonparametric; Treatment Outcome | 2012 |